Bioavailability: Difference between revisions
From WikiLectures
(minor) |
(m) |
||
Line 3: | Line 3: | ||
'''<big>Characteristics</big>''' | '''<big>Characteristics</big>''' | ||
*The greater the F, the greater the amount of drug that reaches the systemic circulation, and thus the greater the drug concentration in plasma and vice versa | |||
The route with the highest F (F=1) is via intravenous (I.V.) administration. The second highest F is achieved through inhalation. The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing first pass metabolism, prior entering to the systemic circulation. | *The route with the highest F (F=1) is via intravenous (I.V.) administration. | ||
*The second highest F is achieved through inhalation. | |||
*The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing *first pass metabolism, prior entering to the systemic circulation. | |||
Revision as of 01:19, 5 July 2014
Definition
- Bioavailability (F) is a pharmacokinetic parameter representing the fraction of a drug dose that reaches the systemic circulation unaltered.
Characteristics
- The greater the F, the greater the amount of drug that reaches the systemic circulation, and thus the greater the drug concentration in plasma and vice versa
- The route with the highest F (F=1) is via intravenous (I.V.) administration.
- The second highest F is achieved through inhalation.
- The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing *first pass metabolism, prior entering to the systemic circulation.
Types
Absolute bioavailability
It is the comparison of the per os bioavailability to the intavenous bioavailability